JP Morgan Maintains Overweight on Inspire Medical Systems, Lowers Price Target to $181
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Robbie Marcus has maintained an Overweight rating on Inspire Medical Systems (NYSE:INSP) but lowered the price target from $340 to $181.
October 17, 2023 | 4:04 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
JP Morgan has maintained an Overweight rating on Inspire Medical Systems but lowered the price target from $340 to $181.
The lowering of the price target by JP Morgan indicates a potential decrease in the stock's value in the short term. However, the Overweight rating suggests that the company is still expected to outperform its peers.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100